{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:52:46Z","timestamp":1763747566445,"version":"3.40.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Red de Investigaci\u00f3n Cooperativa en Enfermedades Tropicales"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.actatropica.2016.09.026","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T20:33:46Z","timestamp":1475267626000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Lymphoproliferative response after stimulation with soluble leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients"],"prefix":"10.1016","volume":"164","author":[{"given":"Alicia","family":"Castro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan V.","family":"San Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Botana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Mat\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Horrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ibarra-Meneses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-7386","authenticated-orcid":false,"given":"Jose M.","family":"Ruiz-Giardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0087-4659","authenticated-orcid":false,"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"March (5)","key":"10.1016\/j.actatropica.2016.09.026_bib0005","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/infdis\/jit418","article-title":"Reversion and conversion of interferon-\u03b3 release assay results in HIV-1-infected individuals","volume":"209","author":"Aichelburg","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"April (2)","key":"10.1016\/j.actatropica.2016.09.026_bib0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.actatropica.2016.09.026_bib0015","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"WHO Leishmaniasis Control Team Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"June (12)","key":"10.1016\/j.actatropica.2016.09.026_bib0020","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/518167","volume":"44","author":"Antinori","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"July (25)","key":"10.1016\/j.actatropica.2016.09.026_bib0025","doi-asserted-by":"crossref","first-page":"20546","DOI":"10.2807\/1560-7917.ES2013.18.30.20546","article-title":"Re-emergence of leishmaniasis in Spain: community outbreak in Madrid Spain, 2009\u20132012","volume":"18","author":"Arce","year":"2013","journal-title":"Eurosurveillance"},{"issue":"December (18)","key":"10.1016\/j.actatropica.2016.09.026_bib0030","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1097\/00002030-200012220-00020","article-title":"Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy","volume":"14","author":"Berenguer","year":"2000","journal-title":"AIDS Lond. Engl."},{"issue":"November (11)","key":"10.1016\/j.actatropica.2016.09.026_bib0035","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/JCM.41.11.5080-5084.2003","article-title":"Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis","volume":"41","author":"Bossolasco","year":"2003","journal-title":"J. Clin. Microbiol."},{"issue":"May (1)","key":"10.1016\/j.actatropica.2016.09.026_bib0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/QAI.0b013e318166af5d","article-title":"Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis","volume":"48","author":"Bourgeois","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"March (3)","key":"10.1016\/j.actatropica.2016.09.026_bib0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s100960100457","article-title":"Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy","volume":"20","author":"Casado","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"March (3)","key":"10.1016\/j.actatropica.2016.09.026_bib0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals \u2013 a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"June (6)","key":"10.1016\/j.actatropica.2016.09.026_bib0055","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1371\/journal.pntd.0001153","article-title":"Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review","volume":"5","author":"Cota","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"April","key":"10.1016\/j.actatropica.2016.09.026_bib0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1756-3305-6-122","article-title":"Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis","volume":"6","author":"Cunha","year":"2013","journal-title":"Parasit Vectors"},{"issue":"Suppl 1","key":"10.1016\/j.actatropica.2016.09.026_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","article-title":"Leishmania\/HIV co-infections: epidemiology in Europe","volume":"97","author":"Desjeux","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"October (7)","key":"10.1016\/j.actatropica.2016.09.026_bib0070","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1086\/377607","article-title":"Effect of highly active antiretroviral therapy on the incidence and clinical manifestations of visceral leishmaniasis in human immunodeficiency virus-infected patients","volume":"37","author":"Fern\u00e1ndez Cotarelo","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"November (2)","key":"10.1016\/j.actatropica.2016.09.026_bib0075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clim.2005.06.015","article-title":"T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani","volume":"117","author":"Hailu","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.actatropica.2016.09.026_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.05.021","article-title":"Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic","author":"Ibarra-Meneses","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"issue":"December (Pt. 6)","key":"10.1016\/j.actatropica.2016.09.026_bib0085","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/icb.1993.64","article-title":"Interferon-gamma and interleukin-4 in human Leishmania donovani infections","volume":"71","author":"Kemp","year":"1993","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.actatropica.2016.09.026_bib0090","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1097\/00002030-199816000-00009","article-title":"Visceral. leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts","volume":"12","author":"Kubar","year":"1998","journal-title":"AIDS"},{"issue":"July (7)","key":"10.1016\/j.actatropica.2016.09.026_bib0095","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1198-743x.2001.00270.x","article-title":"Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART)","volume":"7","author":"L\u00f3pez-V\u00e9lez","year":"2001","journal-title":"Clin. Microbiol. Infect."},{"issue":"November (5)","key":"10.1016\/j.actatropica.2016.09.026_bib0100","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4269\/ajtmh.2006.75.858","article-title":"Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up","volume":"75","author":"Mary","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"August (8)","key":"10.1016\/j.actatropica.2016.09.026_bib0105","doi-asserted-by":"crossref","first-page":"e3021","DOI":"10.1371\/journal.pntd.0003021","article-title":"Visceral leishmaniasis and HIV coinfection in the Mediterranean region","volume":"8","author":"Monge-Maillo","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"June (3)","key":"10.1016\/j.actatropica.2016.09.026_bib0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0035-9203(00)90345-6","article-title":"HIV\u2013Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy","volume":"94","author":"Moreno","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2016.09.026_bib0115","unstructured":"PLOS Neglected Tropical Diseases: Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant. Available: http:\/\/journals.plos.org\/plosntds\/article?id=10.1371\/journal.pntd.0004179."},{"key":"10.1016\/j.actatropica.2016.09.026_bib0120","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf (accessed on 10.17.15.), page 288."},{"issue":"June (11)","key":"10.1016\/j.actatropica.2016.09.026_bib0125","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome","volume":"46","author":"Ter Horst","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"October (10)","key":"10.1016\/j.actatropica.2016.09.026_bib0130","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s100960000364","article-title":"Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy","volume":"19","author":"Villanueva","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"year":"2010","series-title":"Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases","author":"WHO Expert Committee on the Control of the Leishmaniases","key":"10.1016\/j.actatropica.2016.09.026_bib0135"},{"issue":"April (4)","key":"10.1016\/j.actatropica.2016.09.026_bib0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"van Griensven","year":"2014","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X16302911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X16302911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T01:17:46Z","timestamp":1568423866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X16302911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":28,"alternative-id":["S0001706X16302911"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2016.09.026","relation":{},"ISSN":["0001-706X"],"issn-type":[{"type":"print","value":"0001-706X"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoproliferative response after stimulation with soluble leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2016.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}